Repligen | Заемный Капитал



Loan Capital Изменить Дата
Agilent USD 3.35B 2M 2025-01
Align Technology USD 0 0 2024-12
Bio Techne USD 300M 0 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Bruker USD 2.06B 202.7M 2024-12
Charles River Laboratories USD 2.24B 86.45M 2024-12
Danaher USD 15.5B 824M 2024-12
Dentsply International USD 1.59B 209M 2024-12
Exact Sciences USD 2.33B 23K 2024-12
General Electric USD 17.23B 17.23B 2024-12
Henry Schein USD 1.83B 76M 2024-12
Illumina USD 1.49B 498M 2024-12
IQVIA Holdings USD 12.84B 545M 2024-12
Mettler Toledo International USD 1.83B 60.4M 2024-12
Myriad Genetics USD 39.6M 600K 2024-12
Patterson Companies USD 321.76M 3.63M 2025-01
Pfizer USD 57.4B 597M 2024-12
Repligen USD 521.61M 3.89M 2024-09
Revvity USD 3.15B 35.22M 2024-12
Standard Biotools USD 299K 0 2024-12
Thermo Fisher Scientific USD 29.06B 2.14B 2024-12
Waters USD 1.63B 199.76M 2024-12
West Pharmaceutical Services USD 204.7M 100K 2024-12



Repligen Заемный Капитал - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.